Atomo Diagnostics Ltd (AT1) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.145x

Based on the latest financial reports, Atomo Diagnostics Ltd (AT1) has a cash flow conversion efficiency ratio of -0.145x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-962.50K ≈ $-681.03K USD) by net assets (AU$6.64 Million ≈ $4.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see AT1 market cap for the company's overall valuation and market capitalisation.

Atomo Diagnostics Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Atomo Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Atomo Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Atomo Diagnostics Ltd ranked by their cash flow conversion efficiency. See Atomo Diagnostics Ltd cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Solarmax Technology Inc. Common Stock NASDAQ:SMXT	367.037x
RE Royalties Ltd V:RE	0.166x
Eurasia Fonciere Investissements Société Anonyme PA:EFI	-0.015x
S&W Corporation KQ:103230	0.063x
Big Rock Brewery Inc. TO:BR	0.051x
Rewardle Holdings Ltd AU:RXH	-0.038x
Connexion Mobility Ltd AU:CXZ	0.113x
Emerge Commerce Ltd V:ECOM	-0.121x

Annual Cash Flow Conversion Efficiency for Atomo Diagnostics Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of Atomo Diagnostics Ltd from 2017 to 2025. View current stock price of Atomo Diagnostics Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$6.98 Million ≈ $4.94 Million	AU$-1.96 Million ≈ $-1.39 Million	-0.281x	+39.57%
2024-06-30	AU$10.08 Million ≈ $7.14 Million	AU$-4.69 Million ≈ $-3.32 Million	-0.465x	-17.53%
2023-06-30	AU$14.79 Million ≈ $10.47 Million	AU$-5.85 Million ≈ $-4.14 Million	-0.395x	-249.55%
2022-06-30	AU$24.81 Million ≈ $17.56 Million	AU$-2.81 Million ≈ $-1.99 Million	-0.113x	+19.46%
2021-06-30	AU$30.09 Million ≈ $21.29 Million	AU$-4.23 Million ≈ $-2.99 Million	-0.140x	+22.67%
2020-06-30	AU$34.48 Million ≈ $24.40 Million	AU$-6.26 Million ≈ $-4.43 Million	-0.182x	-154.05%
2019-06-30	AU$-5.47 Million ≈ $-3.87 Million	AU$-1.84 Million ≈ $-1.30 Million	0.336x	-70.46%
2018-06-30	AU$-4.89 Million ≈ $-3.46 Million	AU$-5.56 Million ≈ $-3.93 Million	1.137x	+101.03%
2017-06-30	AU$47.82K ≈ $33.83K	AU$-5.26 Million ≈ $-3.72 Million	-109.899x	--

About Atomo Diagnostics Ltd

AU:AT1 Australia Medical Devices

Market Cap

$10.85 Million

AU$15.34 Million AUD

Market Cap Rank

#26953 Global

#1264 in Australia

Share Price

AU$0.02

Change (1 day)

-5.56%

52-Week Range

AU$0.02 - AU$0.04

All Time High

AU$0.57